CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-23 | Vasista Vittal Chief Financial Officer | Sale | −21,124 | $50.01 | $1.1M | 136,400 |
| 2020-12-23 | Mills Kenneth T. President and CEO | Option exercise | +4,500 | $0.85 | $4K | 245,500 |
| 2020-12-23 | Mills Kenneth T. President and CEO | Sale | −4,500 | $50.00 | $225K | 241,000 |
| 2020-12-23 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −4,500 | 55,670 | ||
| 2020-12-16 | Mills Kenneth T. President and CEO | Option exercise | +15,000 | $0.85 | $13K | 256,000 |
| 2020-12-16 | Mills Kenneth T. President and CEO | Sale | −15,000 | $45.00 | $675K | 241,000 |
| 2020-12-16 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 60,170 | ||
| 2020-12-11 | Vasista Vittal Chief Financial Officer | Sale | −14,916 | $40.17 | $599K | 157,524 |
| 2020-12-10 | Vasista Vittal Chief Financial Officer | Sale | −22,584 | $40.06 | $905K | 172,440 |
| 2020-12-10 | Mills Kenneth T. President and CEO | Option exercise | +4,500 | $0.85 | $4K | 245,500 |
| 2020-12-10 | Mills Kenneth T. President and CEO | Sale | −4,500 | $40.00 | $180K | 241,000 |
| 2020-12-10 | Mills Kenneth T. President and CEO | Option exercise · Employee Stock Option (Right to Buy) | −4,500 | 75,170 | ||
| 2020-08-06 | Fox Allan M. Director | Gift | −90,000 | 1,324,110 | ||
| 2020-08-06 | Fox Allan M. Director | Gift | +90,000 | 315,000 | ||
| 2020-07-27 | Fox Allan M. Director | Gift | −225,000 | 1,414,110 | ||
| 2020-07-27 | Fox Allan M. Director | Gift | +225,000 | 225,000 | ||
| 2020-07-15 | Vasista Vittal Chief Financial Officer | Option exercise | +3,259 | $13.09 | $43K | 209,974 |
| 2020-07-15 | Vasista Vittal Chief Financial Officer | Sale | −14,950 | $40.10 | $599K | 195,024 |
| 2020-07-15 | Vasista Vittal Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −3,259 | 14,115 | ||
| 2020-06-30 | Danos Olivier Chief Scientific Officer | Grant or award | +641 | $31.31 | $20K | 7,443 |
Page 21 of 25 · 494 trades